Trial updates in R/R MM from ASCO: ARROW, MMY1001 & OPTIMISMM VJHemOnc – Video Journal of Hematology & HemOnc 6:40 6 years ago 57 Далее Скачать
Randomized trials of pomalidomide combinations for MM VJHemOnc – Video Journal of Hematology & HemOnc 1:56 6 years ago 99 Далее Скачать
OPTIMISMM study update VJHemOnc – Video Journal of Hematology & HemOnc 2:59 4 years ago 41 Далее Скачать
OPTIMISMM: PVd for lenalidomide-refractory myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:36 2 years ago 126 Далее Скачать
UK practice: pomalidomide in patients resistant to lenalidomide VJHemOnc – Video Journal of Hematology & HemOnc 2:31 4 years ago 65 Далее Скачать
Results of the OPTIMISMM study for R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:28 6 years ago 100 Далее Скачать
Dr. Richardson Discusses the Results of the OPTIMISMM Trial in Myeloma OncLive 2:14 6 years ago 174 Далее Скачать
Update on the Phase 3 OPTIMISMM trial International Myeloma Foundation 4:38 6 years ago 219 Далее Скачать
Phase III study of isatuximab, pomalidomide, and low-dose dexamethasone in pts with RRMM International Myeloma Foundation 5:28 5 years ago 479 Далее Скачать
Pomalidomide + Low-Dose Dex + Dara in Relapsed and/or Refractory Multiple Myeloma International Myeloma Foundation 4:01 5 years ago 783 Далее Скачать
OPTIMISMM: benefits of a new triplet therapy for MM patients relapsing on lenalidomide VJHemOnc – Video Journal of Hematology & HemOnc 1:43 5 years ago 72 Далее Скачать
Apollo: pomalidomide plus dexamethasone, with/without daratumumab in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 1:42 3 years ago 210 Далее Скачать
OPTIMISMM: investigating an alternative therapy for lenalidomide-refractory patients VJHemOnc – Video Journal of Hematology & HemOnc 4:58 6 years ago 119 Далее Скачать
The impact of bortezomib dose adjustment in the OPTIMISMM study VJHemOnc – Video Journal of Hematology & HemOnc 0:43 1 year ago 251 Далее Скачать
Triplet Regimens With Pomalidomide in Patients With Multiple Myeloma Targeted Oncology 1:16 6 years ago 247 Далее Скачать
Elotuzumab Plus Pomalidomide and Dexamethasone for Multiple Myeloma NEJM Group 1:41 5 years ago 2 682 Далее Скачать
